Mounjaro approved by U.S. FDA approves type 2 diabetes treatment |
Clinical News
eMediNexus Coverage from: 
Mounjaro approved by U.S. FDA approves type 2 diabetes treatment
eMediNexus,  15 May 2022
Coronavirus Live Count Map India

remove_red_eye 1120 Views
COVID-19 Vaccine Updates



10 Read Comments                

On Friday, the U.S. Food & Drug Administration approved Eli Lillys “Mounjaro” an injected drug tirzepatide to treat adults with type 2 diabetes.According to the FDA, more than 30 million Americans have type 2 diabetes which was the most prevalent type of chronic and progressive disease resulting in excessive blood sugar levels due to improper production of use of insulin by the body.“Mounjaro” in combination with  exercise and diet, pull down blood sugar lev...
To read the complete article ,
create a free account.
Sign Up to instantly read 30000+ free Articles & 1000+ Case Studies
Create Account

Already registered?

Login Now